Purchase Order HHSN261201700002A

This is a $191,851.34 time and materials purchase order awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services (HHS), to Ferguson Martin, a small business, for bioinformatics subject matter expert services in support of the NCI Center for Cancer Genomics. The contract has a base period of 12 months with two 12-month option periods, and was set aside for total small business participation. The services will provide subject matter expertise and...

This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian federal agency, to Matthew Douglas Merguerian, an "Other Not For Profit Organization". The contract is for "PROFESSIONAL SERVICES/PT ON CALL SERVICES" with a ceiling value of $18,775.00 and a period of performance ending on May 10, 2021. The contract was awarded on June 25, 2020 and does not have a set-aside designation. No additional details about a larger contract vehicle...

This $17,053.58 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency, to an undisclosed prime contractor on September 11, 2024. The contract is for a service agreement with a period of performance through March 10, 2025. No set-aside designation is indicated. The contract award does not provide details about the specific products or services to be delivered, but as the NCI is the funding agency, the work is likely related to the institute's cancer...

<p>This is a federal contract award from the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to a prime contractor. The contract has a ceiling value of $679,333.47 and was awarded on August 19, 2016 with a final completion date of September 14, 2020. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type. The place of performance is Columbia, MD. The contract does not have a set-aside designation.</p>

This is a Firm Fixed Price delivery order awarded by the National Cancer Institute (NCI) to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution, for a Single Cell Sequencing Task Order under the NCI Genomic Characterization Centers master IDIQ contract. The period of performance is from September 16, 2019 to September 15, 2022, with a ceiling value of $190,664.68. The order is in support of NCI's Center for Cancer Genomics program and does not have a set-aside...

<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>

This firm fixed price purchase order, awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute, is for $37,785.60 in mRNA and microRNA microarray profiling services to support the prediction of radiation therapy outcomes. The prime contractor is Genus Biosystems Inc., located in Northbrook, Illinois, and no set-aside designation was applied to this procurement. The contract completion date is August 19, 2024, suggesting the National Cancer...

This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Mary Bruce Ganges, a Minority Owned, Woman Owned Small Business. The contract award, valued at $89,990.86, is for biological research consulting services. The contract does not have a set-aside designation and has an ultimate completion date of September 19, 2014. This award is likely associated with the National Cancer Institute's research...

This is a delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to ICF Esac, LLC, a limited liability company that provides strategic consulting and technology services. The contract is for the Proteomics Data Commons (PDC) project, with a period of performance from September 15, 2017 to September 14, 2018, and an ultimate completion date of March 31, 2020. The contract is a Firm Fixed Price Delivery Order under the General Services Administration (GSA) IT Schedule 70...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...